Orexo is a Swedish pharmaceutical company with 30 years of experience developing improved pharmaceuticals based on proprietary drug delivery technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2024 amounted to SEK 590 million, and the number of employees to 110. Orexo is listed on Nasdaq Stockholm’s main list and is available as ADRs on OTCQX market (ORXOY) in the US.
Company Details
- Employees
- 95
- Founded
- -
- Address
- Rapsgatan 7, Fyrislund,uppsala County 754 50,sweden
- Phone
- 46 1 87 80 88 00
- in****@****exo.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- orexo.com
- Keywords
- Drug Delivery, Research & Development, Powder technology, Opioid use Disorder, Commercial-stage, Rescue medications, AmorphOX, Intranasal delivery, Fully-fledge Pharma Co..
- HQ
- Fyrislund, Uppsala County
Orexo Ab Publ. Questions
Orexo Ab Publ.'s helpline number is 46 1 87 80 88 00
Orexo Ab Publ.'s website is orexo.com
Orexo Ab Publ.'s LinkedIn profile is https://www.linkedin.com/company/orexo-ab
Orexo Ab Publ. has
95 employees.
View email and phone details for 95
employees at Orexo Ab Publ..
Orexo Ab Publ.'s industry is
Pharmaceutical Manufacturing
Orexo Ab Publ.'s top competitors are
Orexo Us, Inc.,
Fresenius Kabi,
Diamyd Medical,
Nanexa Ab,
Moberg Pharma Ab,
Oncopeptides Ab (Publ),
Bioarctic,
Emplicure,
Medivir Ab,
Abera Bioscience Ab.
Orexo Ab Publ.'s support email address is info@orexo.com
Orexo Ab Publ.'s categories are Pharmaceutical Manufacturing
Orexo Ab Publ.'s founding year is 1995
